The DOI matches its Crossref record.
PROGRESS IN UREMIC TOXIN RESEARCH: Protein‐Bound Toxins—Update 2009
Abstract
Protein‐bound uremic retention solutes constitute a group whose common characteristic is their difficult removal by dialysis. In 2003, the EUTox group described 25 protein‐bound solutes. They comprised six advanced glycation end products (AGE), four phenols (including p‐cresol), six indoles (including indoxylsulfate), two hippurates, three polyamines, and two peptides, homocysteine and 3‐carboxy‐4‐methyl‐5‐propyl‐2‐furanpropionic acid (CMPF). As then, three new compounds have been added to the list: phenylacetic acid, dinucleoside polyphosphates, and IL‐18. During the last years, protein‐bound compounds have been identified as some of the main toxins involved in vascular lesions of chronic kidney disease. The removal of these solutes by conventional hemodialysis (HD) is low because only the free fraction of the solute is available for diffusion. The increase in the convective part with hemodiafiltration improves the performance of depuration but convection only applies to the free fraction and its benefit is limited. One possibility to improve the removal of a protein‐bound solute would be to stimulate its dissociation from the binding protein. This could be obtained in experiments by setting the dialysate flow rate and the dialyzer mass transfer area coefficient (KoA) at much higher levels than the plasma flow rate, or by adding to the dialysate a sorbent such as activated charcoal or albumin. In the future, specific adsorbents may be developed. Today, the only possibility is to use approaches such as daily HD and long HD which could allow better equilibration between extravascular and vascular compartments and consequently result in greater removal of protein‐bound compounds.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 49
- 10.1046/j.1523-1755.2003.00924.x · DOI · Paper page
- 10.1007/s00467-008-0762-9 · doi:10.1007/s00467-008-0762-9
- 10.1046/j.1523-1755.2001.07805.x · DOI
- 10.1053/j.arrt.2003.08.002 · DOI
- 10.1681/ASN.2005030310 · DOI · Paper page
- 10.1093/ndt/gfl584 · DOI · Paper page
- 10.1038/ki.2008.31 · DOI · Paper page
- 10.1038/sj.ki.5000115 · DOI · Paper page
- Jankowski J, 1998, Characterization of dimethylguanosine, phenylethylamine, and phenylacetic acid asinhibitors of Ca2+ ATPase in end‐stage renal failure, J Am Soc Nephrol, 9, 1249, 10.1681/ASN.V971249 · DOI
- 10.1172/JCI200315524 · DOI
- 10.1093/ndt/gfn266 · DOI
- 10.1093/ndt/gfm475 · DOI
- 10.1093/ndt/gfm455 · DOI
- 10.1080/10408440701638970 · DOI · Paper page
- 10.1007/s00726-006-0264-7 · DOI
- 10.1111/j.1744-9987.2006.00370.x · DOI
- 10.1211/0022357001774372 · DOI
- 10.1111/j.1523-1755.2004.00399.x · DOI · Paper page
- 10.1046/j.1523-1755.2001.07850.x · doi:10.1046/j.1523-1755.2001.07850.x
- Pawlak D, 2003, Kynurenine and its metabolites in the rat with experimental renal insufficiency, J Physiol Pharmacol, 54, 175
- 10.1042/BST0351287 · DOI
- 10.1007/s10571-006-9124-y · DOI
- Karasek M, 2005, Decreased melatonin nocturnal concentrations in hemodialyzed patients, Neuro Endocrinol Lett, 26, 653
- 10.1034/j.1600-079X.2001.310305.x · DOI
- 10.1159/000186729 · doi:10.1159/000186729
- Kancheva R, 2008, Increase of nocturnal melatonin levels in hemodialyzed patients after parathyroidectomy: a pilot study, Physiol Res, 57, S181, 10.33549/physiolres.931503 · doi:10.33549/physiolres.931503
- 10.1097/MNH.0b013e32830f45b6 · DOI
- 10.1093/ndt/gfm861 · DOI · Paper page
- 10.1111/j.1538-7836.2007.02540.x · DOI · Paper page
- 10.1111/j.1538-7836.2005.01780.x · DOI · Paper page
- 10.1046/j.1523-1755.2003.00906.x · DOI · Paper page
- 10.1080/08860220802356531 · DOI
- 10.1159/000074327 · DOI
- 10.1111/j.1365-2362.2004.01418.x · DOI
- 10.1093/ndt/gfn098 · doi:10.1093/ndt/gfn098
- 10.1111/j.1525-139X.2009.00585.x · DOI
- 10.1111/j.1525-139X.2009.00579.x · DOI
- 10.1111/j.1525-139X.2009.00589.x · DOI
- 10.1053/j.ajkd.2007.12.035 · DOI
- 10.1111/j.1523-1755.2000.00398.x · DOI
- 10.1080/15216540500404093 · DOI · Paper page
- 10.1093/ndt/15.1.50 · doi:10.1093/ndt/15.1.50
- 10.1053/j.ajkd.2004.04.033 · doi:10.1053/j.ajkd.2004.04.033
- 10.1093/ndt/gfn522 · doi:10.1093/ndt/gfn522
- 10.1681/ASN.2006080863 · DOI
- 10.1016/j.jbiotec.2005.11.009 · doi:10.1016/j.jbiotec.2005.11.009
- 10.1093/ndt/gfg054 · DOI
- 10.1038/sj.ki.5001640 · DOI
- 10.1038/ncpneph1023 · doi:10.1038/ncpneph1023
Cited by
What do drug transporters really do?
Nigam, S. K. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4461 · Cited by 527
Gryp, T., Vanholder, R., Vaneechoutte, M., & Glorieux, G. (2017) · Toxins · doi:10.3390/toxins9020052 · Cited by 417
Self-citationWatanabe, H., Miyamoto, Y., Honda, D., Tanaka, H., Wu, Q., Endo, M., Noguchi, T., Kadowaki, D., Ishima, Y., Kotani, S., et al. (2013) · Kidney International · doi:10.1038/ki.2012.448 · Cited by 389
Biochemical and Clinical Impact of Organic Uremic Retention Solutes: A Comprehensive Update
Vanholder, R., Pletinck, A., Schepers, E., & Glorieux, G. (2018) · Toxins · doi:10.3390/toxins10010033 · Cited by 356
Self-citationThe Cardiovascular Effect of the Uremic Solute Indole-3 Acetic Acid
Dou, L., Sallée, M., Cerini, C., Poitevin, S., Gondouin, B., Jourde-Chiche, N., Fallague, K., Brunet, P., Calaf, R., Dussol, B., et al. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013121283 · Cited by 329
Self-citation
Metadata
- Authors
- Jourde‐Chiche, N., Dou, L., Cerini, C., Dignat‐George, F., Vanholder, R., & Brunet, P.
- Venue
- Seminars in Dialysis
- Publisher
- Wiley
- Published
- 2009-07
- Volume
- 22
- Issue
- 4
- Pages
- 334-339
- ISSN
- 0894-0959 (ISSN-L)
- 1525-139X
- OpenAlex
- W1827522486
- Cited by
- 159
- References
- 0
- FWCI
- 9.07
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: PROGRESS IN UREMIC TOXIN RESEARCH: Protein‐Bound Toxins—Update 2009. https://app.cochat.ai/papers/10.1111/j.1525-139x.2009.00576.x
- The paper
- Jourde‐Chiche, N., Dou, L., Cerini, C., Dignat‐George, F., Vanholder, R., & Brunet, P. (2009). PROGRESS IN UREMIC TOXIN RESEARCH: Protein‐Bound Toxins—Update 2009. Seminars in Dialysis. https://doi.org/10.1111/j.1525-139x.2009.00576.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.